Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
16 participants
INTERVENTIONAL
2010-01-31
2010-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Use of Lumbar Drain to Remove Clots in Patients Admitted to the Neuro-ICU After Subarachnoid Hemorrhage.
NCT01886521
Cervical Sympathetic Block in Patients With Cerebral Vasospasm
NCT05230134
Safety and Efficacy of L-NAME and Midodrine to Increase MAP
NCT00835224
Prevention of Low Blood Pressure in Persons With Tetraplegia
NCT00237770
Hemodynamic Management Following Acute Traumatic Spinal Cord Injury
NCT06451133
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Stroke volume optimization
Stroke volume optimization
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Lithium therapy
* Type I diabetes or type II requiring insulin
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rigshospitalet, Denmark
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rigshospitalet
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Morten Bundgaard-Nielsen, MD
Role: PRINCIPAL_INVESTIGATOR
Section of surgical pathophysiology
Morten Bundgaard-Nielsen, MD
Role: PRINCIPAL_INVESTIGATOR
unafiliated
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rigshospitalet
Copenhagen, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Morten Bundgaard-Nielsen, MD
Role: primary
Hans-Jørgen B Frederiksen, MD
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Neuroaxial blokade and BP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.